Skip to main content
Premium Trial:

Request an Annual Quote

Veracyte Inks Research Collaboration with GE

NEW YORK (GenomeWeb) – Veracyte today announced that it has signed a research collaboration agreement with GE to develop new diagnostic approaches based on GE Healthcare's digital imaging technology.

The partners will "explore the concept of deriving innovative diagnostic approaches from a combination of digital imaging and genomic technologies," Veracyte CEO Bonnie Anderson said in a statement.

The firms will look to identify features from raw imaging data that, when combined with genomic information, have the potential to inform disease diagnosis.

Veracyte has amassed a large database of clinical, imaging, and genomic information from clinical trials to validate its Afirma gene expression classifier (GEC) tests, the firm said in a statement.

Under the terms of the agreement, Veracyte will collaborate with GE Ventures, GE Healthcare, and the GE Global Research Center to assess the feasibility of combining the two firms' technologies.

Financial and other terms of the agreement were not disclosed.

Last month, Veracyte expanded a co-promotion deal for the Afirma GEC test in Brazil and Singapore with Genzyme.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.